Patent directory · USPTO A61K / A61P
Patents matching “Vertex Pharmaceuticals Incorporated”
980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12187698
Crystalline forms of C21H22Cl2N4O2
granted -
US 12173324
Differentiation of pancreatic endocrine cells
granted -
US 12173337
Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 12168009
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12161674
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
granted -
US 12134767
Materials and methods for treatment of hemoglobinopathies
granted -
US 12129471
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
granted -
US 12121524
DNA-PK inhibitors
granted -
US 12116606
Complement factor I-related compositions and methods
granted -
US 12116343
Inhibitors of APOL1 and methods of using same
granted -
US 12084438
GCN2 inhibitors and uses thereof
granted -
US 12065432
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
granted -
US 12060346
Inhibitors of APOL1 and methods of using same
granted -
US 12053531
Materials and methods for treatment of Duchenne Muscular Dystrophy
granted -
US 12049645
Differentiation of pancreatic endocrine cells
granted -
US 12043843
Materials and methods for treatment of hemoglobinopathies
granted -
US 12031150
Methods, compositions and kits for increasing genome editing efficiency
granted -
US 12005127
DNA-PK inhibitors
granted -
US 12006516
Differentiation of pancreatic endocrine cells
granted -
US 11999971
Stem cell derived islet differentiation
granted -
US 11992506
Stem cell derived pancreatic islet differentiation
granted -
US 11980633
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted -
US 11951206
Cell housing device
granted -
US 11951212
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted